A novel quinazoline derivative induces apoptosis and modulates EGFR/PI3K/AKT/mTOR-related gene expression in glioblastoma cells
The study demonstrates that a newly synthesized quinazoline derivative, KDY23, exhibits potent and moderately selective antitumor activity against glioblastoma cells by inducing apoptosis and downregulating key genes in the EGFR/PI3K/AKT/mTOR signaling pathway.